Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers identify botox receptor

29.09.2003


As doctors tout the toxin found in Botox for its ability to iron out wrinkles, calm muscle spasms and treat migraine headaches, defense agencies condemn it as a weapon that could wipe out large numbers of civilians.



While it is well known that this toxic substance can paralyze the body’s muscles, including the ones that help us breathe, how it infiltrates cells to do this has not been determined.

In a paper published in the Sept. 29 issue of the Journal of Cell Biology, researchers from the University of Wisconsin-Madison answer this long-standing question. They identify a receptor - a route of entry - for the Botox toxin that could lead to improved uses of the substance in the medical field and new methods for neutralizing it in the event of biological warfare.


Botulinum neurotoxin - the toxin found in Botox - is the deadliest of all substances. Produced by different strains of a family of bacteria, it comes in seven forms, four of which are reported to cause the paralyzing and potentially fatal disease of botulism. Currently, the family of bacteria that produces these toxins is listed by the Centers for Disease Control and Prevention as having the greatest potential for mass casualties if used as a biological weapon.

"Botulism is an old disease," says Edwin Chapman, a UW-Madison physiology professor and senior author of the new paper. "We know how the toxins block the release of neurotransmitters from neurons, but we didn’t know how they entered the neurons in the first place."

Whether inhaled or injected, the deadly toxins head straight for neurons, or nerve cells. Via a binding receptor on the surface of these cells, the toxins are brought inside where they block the release of neurotransmitters, chemicals that control muscle contraction and relaxation.

"The way they kill," explains Chapman, "is by inactivating the diaphragm so you no longer can draw a breath."

The receptor that pulls the toxins inside the nerve cells has puzzled scientists. Chapman says researchers have known that gangliosides - a special type of lipid - and proteins work together as a receptor, but no one until now has been able to identify the specific proteins.

Using a cellular model, Chapman, physiology and neuroscience graduate student Min Dong and others identified two proteins that function alongside gangliosides as the receptor for botulinum neurotoxin B - one of the four types deadly to humans. The proteins are synaptotagmin, or syt, I and II, which are found in certain types of neurons.

When one of these two proteins extends itself outside the cell during a process called exocytosis, the toxin latches on and then is internalized during the process of endocytosis.

To confirm that this protein and lipid pair is the actual physiological target of the toxin once it enters the body, the Wisconsin researchers set aside cell cultures and turned to a live mouse model. Working with their colleagues, Michael Goodnough and Eric Johnson in the Department of Food Microbiology and Toxicology, the researchers once again found that the toxin binds to and enters the cell via these two proteins and gangliosides.

"Our study is the first to identify a receptor for one of the botulinum neurotoxins and establish its entry route," says Dong, first author of the paper. "This knowledge will improve both the medical application of the [neurotoxin] and the prevention of a [biological] threat."

Knowledge of this receptor already had led to new research findings that suggest a possible antidote for the toxin.

As described in the paper published September 29, Dong has developed decoys that effectively neutralize one type of the neurotoxin. Specifically, he created fragments of the syt II protein that contain the toxin’s binding site.

In collaboration with Goodnough and Johnson, these fragments, along with gangliosides, were injected into the bloodstream of mice recently exposed to the toxin. The researchers found that the fragments neutralized most of toxic substance; injecting the fragments one minute prior to exposure neutralized 70 to 80 percent of the toxin.

As Chapman explains, "The fragments are a protective agent - a scavenger - that prevents the toxin from reaching its target."

These findings, says Dong, not only confirm the results from the cell culture studies but also provide some of the first evidence that identification of the receptor could play an integral role in developing measures that counteract the bacterial toxin, thereby safeguarding human lives against exposure to the lethal poison.

The fragment composed of the syt II protein is being patented by the Wisconsin Alumni Research Foundation, a non-profit agency that manages intellectual property for UW-Madison.

Currently, Dong and others are working to identify receptors for the other types of botulinum neurotoxin fatal to humans.


CONTACT:
Min Dong, 608-263-4166, mdong@wisc.edu
Edwin Chapman, 608-263-1762, chapman@physiology.wisc.edu
Emily Carlson 608-262-9772, emilycarlson@wisc.edu

Min Dong | idw
Further information:
http://www.wisc.edu/

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>